Presenile-Onset Cerebral Adrenoleukodystrophy Presenting as Balint's Syndrome and Dementia
Neurol 43:1249-1251, Uyama,E.,et al, 1993
Brief Report:Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers
NEJM 329:396-398, 4261993., Winterkorn,J.M.S.,et al, 1993
Functional Image of Dynamic CT in Diagnostic & Prognostic Eval of Ischemic Stroke within the First 6 Hours
Stroke 24:1933-1944, Toriyama,T.,et al, 1993
Characvteristics of Medial Temporal Lobe Epilepsy:I. Results of History and Physical Examination
Ann neurol 34:774-780, French,J.A.,et al, 1993
Parkinsonism Unmasked by Verapamil
Clinical Neuropharmacol 16:263-265, Garcia-Albea,E.,et al, 1993
Olfactory Testing Differentiates Between Progressive Supranuclear Palsy & Idiopathic Parkinson's Dis
Neurol 43:962-965, Doty,R.L.,et al, 1993
Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993
Multiple System Atrophy & Prog Supranuc Palsy, Dimin Striatal D2 Dopamine Receptor Act by SPECT
Arch Neurol 50:513-516, vanRoyen,E.,et al, 1993
Faithful Fashion:Survival Status of the Brain Transplant Cure for Parkinsonism
Neurol 43:644-649, Landau,W.M., 1993
Practice Parameters:Initial Therapy of Parkinson's Disease
Report of the Quality Standards Subcommittee of AAN, Neurol 43:1296-12971993., , 1993
Clinical Experience with Controlled-Release Carbidopa/Levodopa in Parkinson's Disease
Neurol 43:677-681, Pahwa,R.,et al, 1993
Neurosurgical Horizons in Parkinson's Disease
Neurol 43:1-7, Goetz,C.G.,et al, 1993
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Arch Neurol 50:140-148, Hughes,A.J.,et al, 1993
Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993
Aspartame Use in Parkinson's Disease
Neurol 43:611-613, Karstaedt,P.J.&Pincus,J.H., 1993
Nigral Dysfunction in Drug-Induced Parkinsonism:An F-dopa PET Study
Neurol 43:552-556, Burn,D.J.&Brooks,D.J., 1993
Transient Neurologic and Ocular Manifestations in Primary Thrombocythemia
Neurol 43:1107-1110, Michiels,J.J.,et al, 1993
Factors that Predict Antiphospholipid Immunoreactivity in Young People with Transient Focal Neurological Events
Arch Neurol 50:833-836, Tietjen,G.E.,et al, 1993
Functional Integration of Cortical Grafts Placed in Brain Infarcts of Rats
Ann Neurol 34:362-368, Grabowski,M.,et al, 1993
Transplants for Stroke Patients
Ann Neurol 34:322-323, Sharp,F.R., 1993
Subcortical Dementia
BMJ 307:1-2, Dunne,F.J., 1993
The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993
Thalamic Stimulation & Prox Tremor, A Specific Target in Nucleus Ventrointermedius Thalamik
Arch Neurol 50:498-500, Nguyen,J-P.&Degos,J-D., 1993
Progression After Chronic Manganese Exposure
Neurol 43:1479-1483, Huang,C.C.,et al, 1993
Psychiatric and Otologic Diagnoses in Patients Complaining of Dizziness
Arch Int Med 153:1479-1484, Sullivan,M.,et al, 1993
Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993
Aseptic Meningitis in Infants Younger Than 2 Years of Age:Acute Illness and Neurologic Complciations
Pediatrics 92:206-211, Rorabaugh,M.L.,et al, 1993
Mollarte's Meningitis Associated with Herpes Simplex Virus 2 Infection
Neurol 43:1722-1727, Picard,F.J.,et al, 1993
The Management of Acute Visual Failure
JNNP 56:234-240, Wray,S.H., 1993
Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993
Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993
Comparison of Striatal 18F-dopa Uptake in Adult-Onset Dystonia-Parkinsonism, Parkinson's & Dopa-Responsive Dystonia
Neurol 43:1563-1568, Turjanski,N.,et al, 1993
Identical Twins with Similar Onset of Parkinson's Disease:A Case Report
Neurol 43:1159-1161, Pahwa,R.,et al, 1993
Parkinson's Disease:A Test of the Multifactorial Etiologic Hypothesis
Neurol 43:1173-1180, Semchuk,K.M.,et al, 1993
Environmental Causation of Parkinson's Disease
Arch Neurol 50:651-652, Rajput,A.H., 1993
The Nonenvironmental Basis for Rising Mortality from Parkinson's Disease
Arch Neurol 50:653-656, Riggs,J.E., 1993
Cerebellar Infarction, Clinical and Anatomic Observations in 66 Cases
Stroke 24:76-83, Kase,C.S.,et al, 1993
Anterior Inferior Cerebellar Artery Territory Infarcts, Mechanisms and Clinical Features
Arch Neurol 50:154-161, Amarenco,P.,et al, 1993
Pick's Disease Versus Alzheimer's Disease:A Comparison of Clinical Characteristics
Neurol 43:289-292, Mendez,M.F.,et al, 1993
The Clinical Spectrum of Unruptured Intracranial Aneurysms
Arch Neurol 50:265-268, Raps,E.C.,et al, 1993
Transient Monocular Blindness Associated with Cocaine Abuse
Neurol 43:228-229, Libman,R.B.,et al, 1993
Wilson's Disease:Evidence of Subgroups Derived from Clinical Findings and Brain Lesions
Neurol 43:120-124, Oder,W.,et al, 1993
Rapidly Progressive Aphasic Dementia and Motor Neuron Disease
Ann Neurol 33:200-207, Caselli,R.J.,et al, 1993
Dopaminergic Treatment of Restless Legs and Rebound Phenomenon
Neurol 43:455, Guilleminault,C.,et al, 1993
Movement Disorders with Cerebral Toxoplasmosis and AIDS
Movement Disorders 8:107-112, Nath,A.,et al, 1993
Inherited Prion Disease (PrP lysine 200) in Britain:Two Case Reports
BMJ 306:301-302, 2881993., Collinge,J.,et al, 1993
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group, NEJM 328:176-1831993., , 1993
The Antiparkinson Efficacy of Deprenyl Derives from Transient Improvement that is Likely to be Symptomatic
Ann Neurol 32:795-798, Schulzer,M.,et al, 1992
The Free Radical Hypothesis in Idiopathic Parkinsonism:Evidence Against It
Ann Neurol 32:799-803, Calne,D.B., 1992
The Oxident Stress Hypothesis in parkinson's Disease:Evidence Supporting it
Ann Neurol 32:804-812, Fahn,S.&Cohen,G., 1992